Inherited chromosomally integrated human herpesvirus-6 in a patient with XIAP deficiency.
Kento InoueHiroki MiuraAkihiro HoshinoTakahiro KamiyaKay TanitaTamae OhyeMyoung-Ja ParkMasakatsu YanagimachiMasatoshi TakagiKohsuke ImaiTomohiro MorioTetsushi YoshikawaHirokazu KaneganePublished in: Transplant infectious disease : an official journal of the Transplantation Society (2020)
Human herpesvirus-6 (HHV-6) is a common pathogen affecting the human population. Primary HHV-6 infection generally occurs during infancy and causes exanthema subitum. Moreover, HHV-6 may exhibit inherited chromosomally integrated HHV-6 (iciHHV-6) in certain individuals. Although iciHHV-6 is generally known to be nonpathogenic, it may cause reactivation in patients with primary immunodeficiency disease (PID). XIAP deficiency is a rare PID characterized by recurrent hemophagocytic lymphohistiocytosis (HLH). It has been reported that the Epstein-Barr virus primarily causes HLH; however, the other pathogens, including HHV-6, can also cause this complication. We encountered a case of XIAP deficiency accompanied by iciHHV-6. He suffered from recurrent HLH, for which allogeneic bone marrow transplantation (BMT) was performed as a curative therapy. During the course of BMT, the patient experienced HLH three times, but there was no reactivation of endogenous HHV-6 from iciHHV-6. Finally, the patient achieved complete donor chimerism and a decline in HHV-6 DNA copy number in whole blood. This case report demonstrates no evidence of reactivation of iciHHV-6 during BMT in a patient with XIAP deficiency.
Keyphrases
- case report
- endothelial cells
- epstein barr virus
- bone marrow
- copy number
- mitochondrial dna
- induced pluripotent stem cells
- diffuse large b cell lymphoma
- pluripotent stem cells
- mesenchymal stem cells
- replacement therapy
- stem cells
- gene expression
- physical activity
- low dose
- single molecule
- rectal cancer
- smoking cessation
- gram negative
- circulating tumor cells